Type 2 Diabetes Medications That Induce Weight Loss
Mar 22, 2024 · Our easy-to-read fact sheets provide clinicians with reliable information to share with patients and their caregivers. A predominant risk factor for type 2 diabetes is being overweight or obese, so weight loss goals while maintaining normal blood sugar levels are very important for some patients.
The 2024 Update to the American Diabetes Association Standards …
Jan 12, 2024 · The American Diabetes Association (ADA) has updated its guidelines for the “Standards of Care” for patients with diabetes. The report has been published in Diabetes Care.. In the 2024 update, the ADA focused on patient-centered care, person-first language, and updated screening and treatment approaches based on the latest clinical evidence.
Diabetes and Erectile Dysfunction - Endocrinology Advisor
Nov 29, 2024 · Erectile dysfunction is a persistent pattern of being unable to attain and/or maintain a penile erection sufficient for sexual satisfaction. 1 It is a common problem, affecting approximately 30 million men in the United States. 1 Compared to those without diabetes, men with diabetes have an increased risk of developing erectile dysfunction. 2 This article describes how diabetes contributes to ...
Gestational Diabetes Screening Guidelines Updated by the ACOG
Jul 26, 2024 · The USPSTF data show that gestational diabetes diagnosis rates are higher with the 1-step 75-gram OGTT (11.5%) compared with the 2-step 50-gram and 100-gram OGTT screening test (4.9%).
How Do GLP-1 Receptor Agonists, Like Ozempic or Mounjaro, Work?
Jun 14, 2024 · Our easy-to-read fact sheets provide clinicians with reliable information to share with patients and their caregivers. Glucagon-like peptide-1 (GLP-1) is a hormone released when food is eaten to slow gastric emptying, the process by which food leaves the stomach, so that the body can absorb nutrients from food.
SGLT2 Inhibitors - Endocrinology Advisor
Oct 9, 2024 · UGT = UDP-glucuronosyltransferase. From the FDA-approved prescribing information for each medication. 5-9 Warnings and Adverse Reactions. All SGLT2 inhibitors are contraindicated for patients who have hypersensitive reactions to SGLT2 inhibitor treatment. 5-9 Bexagliflozin, canagliflozin, and empagliflozin are not recommended for improving glycemic control in patients with type 2 diabetes who ...
GLP-1 Agonists - Endocrinology Advisor
Oct 8, 2024 · Glucagon-like peptide-1 receptor agonists (GLP-1 agonists) are a newer class of medications that are US Food and Drug Administration (FDA)-approved to manage type 2 diabetes and obesity in conjunction with diet and lifestyle changes. 1 GLP-1 agonists affect glycemic control and body weight by increasing insulin production and release in a glucose-dependent manner; decreasing glucagon secretion ...
Addison's Disease - Endocrinology Advisor
Apr 2, 2024 · Addison’s disease — also referred to as primary adrenal insufficiency — occurs when the adrenal glands do not produce enough cortisol and/or aldosterone, hormones necessary for regulation of metabolism, blood pressure, immune system functions, the stress response, and other essential physiologic activities. 1 Patients with Addison’s disease experience weakness, fatigue, anorexia ...
Diabetic Ketoacidosis (DKA) - Endocrinology Advisor
Apr 2, 2024 · Diabetic ketoacidosis (DKA) is an acute complication of diabetes that results from absolute or relative insulin deficiency. 1,2 It is characterized by the presence of metabolic acidosis, ketonemia, and hyperglycemia. 2 With prompt treatment, most patients with DKA recover, but in rare cases, such as patients who develop cerebral edema or have an underlying illness, DKA can become life ...
Fasting and Diabetes: Understanding the Latest Guidelines
Aug 23, 2024 · References: 1. American Diabetes Association Professional Practice Committee, El Sayed NA, Aleppo G, et al. Facilitating positive health behaviors and well-being to improve health outcomes: standards of care in diabetes—2024. Diabetes Care. 2024;47(Supplement_1):S77-S110. doi:10.2337/dc24-S005 2. Hassanein M, Afandi B, Yakoob Ahmedani M, et al. Diabetes and Ramadan: practical guidelines 2021.